Kimberly-Clark
Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Health Industry
Kimberly-Clark’s landmark $48.7 billion acquisition of Kenvue, the owner of Tylenol and Band-Aid, marks a seismic shift in the consumer staples sector, merging iconic brands and creating one of the industry’s largest players.
4 Key Stocks to Watch This Thursday: AVGO, LULU, KMB, and PG
This Thursday, investors are closely monitoring AVGO, LULU, KMB, and PG, reflecting broader market dynamics amidst tariff uncertainty and earnings outlooks.